MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/10428194.2021.2002321

Медицинская библиотека · Leukemia & lymphoma · 2022

Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy.

Miyamoto Toshihiro, Sanford David, Tomuleasa Ciprian, Hsiao Hui-Hua, Olivera Leonardo José Enciso, Enjeti Anoop Kumar, Gimenez Conca Alberto, Castillo Teresa Bernal Del, Girshova Larisa, Martelli Maria Paola, Guvenc Birol, Delgado Alexander, Duan Yinghui, Garbayo Guijarro Belen, Llamas Cynthia, Lee Je-Hwan

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Acute myeloid leukemia (AML) predominantly affects the elderly, and prognosis declines with age. Induction chemotherapy plus consolidation therapy is standard of care for fit patients; options for unfit patients include hypomethylating agents (HMA), low-dose cytarabine (LDAC), targeted therapies, and best supportive care (BSC). This retrospective chart review evaluated clinical outcomes in unfit patients with AML who initiated first-line treatment or BSC 01/01/2015-12/31/2018. Overall survival (OS), progression-free survival (PFS), time-to-treatment failure (TTF), and response rates were assessed. Of 1762 patients, 1310 received systemic therapies: 809 HMA, 199 LDAC, and 302 other therapies; 452 received BSC. Median OS was 9.9, 7.9, 5.4, and 2.5 months for HMA, LDAC, other, and BSC, respectively. Median PFS was 7.5, 5.3, 4.1, and 2.1 months for HMA, LDAC, other, and BSC, respectively; median TTF was 4.9, 2.1, 2.2, and 2.1 months, respectively. Our findings highlight the unmet need for novel therapies for unfit patients.

Для цитирования: Miyamoto Toshihiro, Sanford David, Tomuleasa Ciprian, Hsiao Hui-Hua, Olivera Leonardo José Enciso, Enjeti Anoop Kumar, Gimenez Conca Alberto, Castillo Teresa Bernal Del, Girshova Larisa, Martelli Maria Paola, Guvenc Birol, Delgado Alexander, Duan Yinghui, Garbayo Guijarro Belen, Llamas Cynthia, Lee Je-Hwan. Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy.. Leukemia & lymphoma. 2022. DOI: 10.1080/10428194.2021.2002321.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.